BMRN BioMarin Pharmaceutical | $82.17
-9.9% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 4/25/2024 |
HUM Humana | $311.41
-1.4% | 4/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/25/2024 |
ENVX Enovix | $5.84
-3.0% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 4/25/2024 |
LRCX Lam Research | $901.47
+1.9% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/25/2024 |
TER Teradyne | $108.91
+8.2% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 4/25/2024 |
AMED Amedisys | $91.16
+0.1% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $101.00 | Low | View details for Cantor Fitzgerald rating of Amedisys (NASDAQ:AMED) on 4/25/2024 |
|
TXN Texas Instruments | $175.25
+0.3% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
ITCI Intra-Cellular Therapies | $72.13
-1.4% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/24/2024 |
ANNX Annexon | $4.59
+3.1% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/24/2024 |
STX Seagate Technology | $87.26
+0.2% | 4/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 4/24/2024 |
MTLS Materialise | $5.08
-3.6% | 4/24/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $9.50 | Low | View details for Cantor Fitzgerald rating of Materialise (NASDAQ:MTLS) on 4/24/2024 |
ABEO Abeona Therapeutics | $3.19
+0.6% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $36.00 | N/A | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/23/2024 |
CDTX Cidara Therapeutics | $13.00
+5.8% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2024 |
INCY Incyte | $51.18
-1.1% | 4/23/2024 | Initiated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 4/23/2024 |
TSHA Taysha Gene Therapies | $2.30
-2.1% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/18/2024 |
ASND Ascendis Pharma A/S | $136.93
-4.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/18/2024 |
BHVN Biohaven | $38.54
-0.5% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/18/2024 |
GPCR Structure Therapeutics | $38.98
+7.0% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/18/2024 |
MRK Merck & Co., Inc. | $130.71
+2.9% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/18/2024 |
NVO Novo Nordisk A/S | $125.80
-0.3% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/18/2024 |
CMPS COMPASS Pathways | $7.86
-3.0% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/18/2024 |
COUR Coursera | $11.73
-1.6% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/17/2024 |
CRWD CrowdStrike | $298.02
+0.1% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 4/17/2024 |
CYBR CyberArk Software | $245.07
+0.2% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/17/2024 |
DDOG Datadog | $125.25
-1.4% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $150.00 | N/A | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 4/17/2024 |
FTNT Fortinet | $64.03
-2.2% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/17/2024 |
NET Cloudflare | $86.76
-1.0% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 | N/A | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 4/17/2024 |
PANW Palo Alto Networks | $288.79
-1.7% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $350.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
ZS Zscaler | $174.81
-1.5% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/17/2024 |
KVYO Klaviyo | $23.01
+0.5% | 4/16/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 4/16/2024 |
REGN Regeneron Pharmaceuticals | $890.68
-1.7% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/15/2024 |
LLY Eli Lilly and Company | $724.87
-1.0% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/15/2024 |
JNJ Johnson & Johnson | $146.82
-1.2% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 4/15/2024 |
PFE Pfizer | $25.26
-3.8% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/15/2024 |
ALXO ALX Oncology | $16.87
+4.0% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 4/12/2024 |
PSNY Polestar Automotive Holding UK | $1.17
-5.6% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 4/12/2024 |
MRVL Marvell Technology | $67.48
+4.1% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 4/12/2024 |
HRMY Harmony Biosciences | $28.93
-1.0% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 4/12/2024 |
PTCT PTC Therapeutics | $25.49
+1.1% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 4/12/2024 |
SOUN SoundHound AI | $4.16
+3.7% | 4/11/2024 | Upgraded by | Cantor Fitzgerald | - | Underweight -> Neutral | $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 4/11/2024 |
What is the 72-Hour Profit Surge? (Ad) One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge...
A short period of time where we can bet on a stock that is ALREADY “winning.”
Let me give you a perfect example of how the Surge worked with Ross Stores.
Back on November 16th, a little move was made that sent their stock soaring…
The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. |
PRTA Prothena | $20.56
| 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 4/10/2024 |
BHVN Biohaven | $38.54
-0.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/10/2024 |
RCM R1 RCM | $11.82
-0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 4/10/2024 |
SGRY Surgery Partners | $24.84
-2.6% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 4/10/2024 |
TBRG TruBridge | $7.85
-0.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 4/10/2024 |
THC Tenet Healthcare | $97.50
-0.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 4/10/2024 |
UHS Universal Health Services | $165.10
-0.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Underweight -> Underweight | $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 4/10/2024 |
UNH UnitedHealth Group | $493.88
+1.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/10/2024 |
AWH Aspira Women's Health | $3.28
-3.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/10/2024 |
ACAD ACADIA Pharmaceuticals | $16.31
-1.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/10/2024 |
AXSM Axsome Therapeutics | $71.52
+0.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/10/2024 |
JAZZ Jazz Pharmaceuticals | $107.43
-0.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 4/10/2024 |
LBPH Longboard Pharmaceuticals | $19.25
-2.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/10/2024 |
MRNS Marinus Pharmaceuticals | $1.42
-1.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/10/2024 |
NBIX Neurocrine Biosciences | $137.76
-0.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 | Low | View details for Cantor Fitzgerald rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/10/2024 |
XENE Xenon Pharmaceuticals | $40.10
+1.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 4/10/2024 |
CI The Cigna Group | $354.50
+0.6% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 4/10/2024 |
CVS CVS Health | $67.32
-0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/10/2024 |
ELV Elevance Health | $539.70
+1.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/10/2024 |
HCA HCA Healthcare | $314.12
-1.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 4/10/2024 |
HCAT Health Catalyst | $5.60
-7.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 4/10/2024 |
HUM Humana | $311.41
-1.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/10/2024 |
AGIO Agios Pharmaceuticals | $31.67
| 4/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 4/9/2024 |
VINC Vincerx Pharma | $0.90
-3.2% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/9/2024 |
GPCR Structure Therapeutics | $38.98
+7.0% | 4/9/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/9/2024 |
NXPI NXP Semiconductors | $238.08
+1.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/8/2024 |
KLAC KLA | $672.95
+2.5% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 -> $800.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 4/8/2024 |
LRCX Lam Research | $901.47
+1.9% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 -> $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/8/2024 |
MU Micron Technology | $111.58
-0.2% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $135.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 4/8/2024 |
QCOM QUALCOMM | $163.30
-0.2% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 -> $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 4/8/2024 |
TXN Texas Instruments | $175.25
+0.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/8/2024 |
WDC Western Digital | $69.44
-0.2% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 4/8/2024 |
GFS GLOBALFOUNDRIES | $47.79
+1.0% | 4/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Neutral | $70.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 4/8/2024 |
AMAT Applied Materials | $197.50
+0.7% | 4/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Overweight | $220.00 -> $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 4/8/2024 |
CABA Cabaletta Bio | $12.18
-6.0% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 4/5/2024 |
RARE Ultragenyx Pharmaceutical | $43.85
-1.0% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/5/2024 |
ETNB 89bio | $8.25
-3.8% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 4/5/2024 |
MRK Merck & Co., Inc. | $130.71
+2.9% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/5/2024 |
MOH Molina Healthcare | $352.30
-4.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 4/4/2024 |
UNH UnitedHealth Group | $493.88
+1.4% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/4/2024 |
SPRO Spero Therapeutics | $1.43
+0.7% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 4/4/2024 |
STOK Stoke Therapeutics | $11.69
+0.3% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 4/4/2024 |
ATAI Atai Life Sciences | $1.84
-1.6% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Atai Life Sciences (NASDAQ:ATAI) on 4/4/2024 |
PRE Prenetics Global | $4.97
+3.8% | 4/4/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 4/4/2024 |
CNC Centene | $75.68
-0.7% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 4/4/2024 |
CVS CVS Health | $67.32
-0.7% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/4/2024 |
ELV Elevance Health | $539.70
+1.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/4/2024 |
HUM Humana | $311.41
-1.4% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/4/2024 |
TNGX Tango Therapeutics | $7.33
-5.5% | 4/4/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 4/4/2024 |
INTC Intel | $35.11
+1.8% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 4/3/2024 |
The Hard Truth About Investing For Retirement (Ad) Here’s the cold, hard truth about investing:
The more capital you have, the more risk averse you can afford to be.
But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive.
In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! |
ANNX Annexon | $4.59
+3.1% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/3/2024 |
PRCH Porch Group | $3.21
-2.4% | 4/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Siegler | Overweight -> Overweight | $3.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 4/3/2024 |
RIVN Rivian Automotive | $8.52
-3.6% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 4/3/2024 |
LEGN Legend Biotech | $44.42
-1.7% | 4/3/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $82.00 | Low | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 4/3/2024 |
AFMD Affimed | $4.88
| 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 4/1/2024 |
CRVS Corvus Pharmaceuticals | $1.48
-2.0% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 4/1/2024 |
VINC Vincerx Pharma | $0.90
-3.2% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/1/2024 |
ATNM Actinium Pharmaceuticals | $6.56
-7.1% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/1/2024 |
AWH Aspira Women's Health | $3.28
-3.5% | 4/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $4.00 -> $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/1/2024 |
HUMA Humacyte | $3.90
+2.1% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Humacyte (NASDAQ:HUMA) on 4/1/2024 |
ZVRA Zevra Therapeutics | $4.52
-0.9% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/1/2024 |
SCYX SCYNEXIS | $1.47
-2.0% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 4/1/2024 |
ASND Ascendis Pharma A/S | $136.93
-4.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/1/2024 |
LLY Eli Lilly and Company | $724.87
-1.0% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/1/2024 |
NVO Novo Nordisk A/S | $125.80
-0.3% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/1/2024 |
PFE Pfizer | $25.26
-3.8% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/1/2024 |
MIGI Mawson Infrastructure Group | $1.39
+3.7% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1.00 | Low | View details for Cantor Fitzgerald rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/1/2024 |
EVLV Evolv Technologies | $3.94
-3.7% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/28/2024 |
CMCL Caledonia Mining | $10.18
+1.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Speculative Buy -> Hold | | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 3/28/2024 |
CLSK CleanSpark | $19.54
-1.2% | 3/28/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $20.00 | N/A | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 3/28/2024 |
BITF Bitfarms | $2.01
-2.9% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 3/28/2024 |
CIFR Cipher Mining | $4.43
-4.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/28/2024 |
IREN Iris Energy | $5.17
-1.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 3/28/2024 |
RIOT Riot Platforms | $12.11
+1.9% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/28/2024 |
WULF TeraWulf | $2.49
-1.2% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/28/2024 |
OUST Ouster | $7.47
+0.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/28/2024 |
MREO Mereo BioPharma Group | $2.81
+1.1% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/28/2024 |
HRMY Harmony Biosciences | $28.93
-1.0% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 3/28/2024 |
CXM Sprinklr | $11.84
-1.2% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
ZS Zscaler | $174.81
-1.5% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/27/2024 |
MRK Merck & Co., Inc. | $130.71
+2.9% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 3/27/2024 |
VNRX VolitionRx | $0.89
+11.2% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 3/27/2024 |
SMTI Sanara MedTech | $32.21
-0.9% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 -> $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/27/2024 |
LUCD Lucid Diagnostics | $0.67
-1.5% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.80 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/27/2024 |
LUNR Intuitive Machines | $5.43
-0.4% | 3/22/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/22/2024 |
JAZZ Jazz Pharmaceuticals | $107.43
-0.8% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/22/2024 |
CLDX Celldex Therapeutics | $36.26
-2.1% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 3/22/2024 |
CABA Cabaletta Bio | $12.18
-6.0% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
DESP Despegar.com | $12.78
+1.5% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/22/2024 |
MREO Mereo BioPharma Group | $2.81
+1.1% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/22/2024 |
CPRX Catalyst Pharmaceuticals | $14.68
-2.9% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/22/2024 |
SOUN SoundHound AI | $4.16
+3.7% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Underweight | $5.80 -> $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/20/2024 |
NVO Novo Nordisk A/S | $125.80
-0.3% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 3/20/2024 |
TSHA Taysha Gene Therapies | $2.30
-2.1% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/20/2024 |
WULF TeraWulf | $2.49
-1.2% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/20/2024 |
JANX Janux Therapeutics | $47.10
-2.3% | 3/20/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 3/20/2024 |
BBIO BridgeBio Pharma | $24.33
-2.8% | 3/19/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 3/19/2024 |
SHLS Shoals Technologies Group | $8.26
-2.7% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $19.25
-2.5% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
GDYN Grid Dynamics | $9.94
-2.9% | 3/13/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 3/13/2024 |
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%...
Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 |
JNJ Johnson & Johnson | $146.82
-1.2% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 3/13/2024 |
CRWD CrowdStrike | $298.02
+0.1% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/14/2024 |
CPRX Catalyst Pharmaceuticals | $14.68
-2.9% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/14/2024 |
MNKD MannKind | $4.18
-0.2% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 3/15/2024 |
DESP Despegar.com | $12.78
+1.5% | 3/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/15/2024 |
SSTI SoundThinking | $13.43
-0.2% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 3/15/2024 |
MU Micron Technology | $111.58
-0.2% | 3/18/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/18/2024 |
RNA Avidity Biosciences | $23.83
-5.0% | 3/14/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Avidity Biosciences (NASDAQ:RNA) on 3/14/2024 |
FROG JFrog | $40.47
+1.6% | 3/7/2024 | Target Raised by | Cantor Fitzgerald | - | | $40.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EVGO EVgo | $1.71
-0.6% | 3/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $5.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 3/7/2024 |
ISPO Inspirato | $3.90
-2.5% | 3/7/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Inspirato (NASDAQ:ISPO) on 3/7/2024 |
DESP Despegar.com | $12.78
+1.5% | 3/7/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/7/2024 |
CIFR Cipher Mining | $4.43
-4.5% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/6/2024 |
NPCE NeuroPace | $12.99
-4.2% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $16.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/6/2024 |
CERS Cerus | $1.70
+2.4% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 3/6/2024 |
CRWD CrowdStrike | $298.02
+0.1% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $360.00 -> $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
RIGL Rigel Pharmaceuticals | $1.10
-1.8% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $2.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/6/2024 |
THC Tenet Healthcare | $97.50
-0.8% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 3/5/2024 |
ACHC Acadia Healthcare | $73.38
+3.1% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $90.00 | Low | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 3/5/2024 |
HCA HCA Healthcare | $314.12
-1.5% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 3/5/2024 |
HCAT Health Catalyst | $5.60
-7.1% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 3/5/2024 |
RCM R1 RCM | $11.82
-0.2% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 3/5/2024 |
SGRY Surgery Partners | $24.84
-2.6% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 3/5/2024 |
TBRG TruBridge | $7.85
-0.9% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/5/2024 |
GTLB GitLab | $56.01
-0.7% | 3/5/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 3/5/2024 |
NVDA NVIDIA | $826.32
+3.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $900.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/4/2024 |
NXPI NXP Semiconductors | $238.08
+1.3% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 3/4/2024 |
TXN Texas Instruments | $175.25
+0.3% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 3/4/2024 |
QCOM QUALCOMM | $163.30
-0.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 3/4/2024 |
TER Teradyne | $108.91
+8.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/4/2024 |
STX Seagate Technology | $87.26
+0.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 3/4/2024 |
AVGO Broadcom | $1,294.42
+3.0% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 -> $1,600.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 3/4/2024 |
AMAT Applied Materials | $197.50
+0.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $220.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 3/4/2024 |
AMD Advanced Micro Devices | $153.76
+1.3% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 3/4/2024 |
KLAC KLA | $672.95
+2.5% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 3/4/2024 |
LRCX Lam Research | $901.47
+1.9% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 3/4/2024 |
ADI Analog Devices | $197.94
+0.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 3/4/2024 |
CI The Cigna Group | $354.50
+0.6% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $372.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 3/4/2024 |
PAGS PagSeguro Digital | $11.82
+1.0% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $16.00 | Low | View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 3/4/2024 |
CRNX Crinetics Pharmaceuticals | $42.29
-2.4% | 3/4/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/4/2024 |
RIOT Riot Platforms | $12.11
+1.9% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/4/2024 |
ETNB 89bio | $8.25
-3.8% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 3/4/2024 |
BBAI BigBear.ai | $1.67
-1.2% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 3/4/2024 |
EVLV Evolv Technologies | $3.94
-3.7% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/1/2024 |
PTCT PTC Therapeutics | $25.49
+1.1% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 3/1/2024 |
AVPT AvePoint | $7.92
+0.1% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of AvePoint (NASDAQ:AVPT) on 3/1/2024 |
SOUN SoundHound AI | $4.16
+3.7% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.60 -> $5.80 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/1/2024 |
MVIS MicroVision | $1.42
-0.7% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.00 | Low | View details for Cantor Fitzgerald rating of MicroVision (NASDAQ:MVIS) on 3/1/2024 |
PFE Pfizer | $25.26
-3.8% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 3/1/2024 |
ZS Zscaler | $174.81
-1.5% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $250.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/1/2024 |
What is the 72-Hour Profit Surge? (Ad) One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge...
A short period of time where we can bet on a stock that is ALREADY “winning.”
Let me give you a perfect example of how the Surge worked with Ross Stores.
Back on November 16th, a little move was made that sent their stock soaring…
The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. |
CPRX Catalyst Pharmaceuticals | $14.68
-2.9% | 3/1/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $27.00 -> $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/1/2024 |
PAYO Payoneer Global | $4.93
-0.6% | 3/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Payoneer Global (NASDAQ:PAYO) on 3/1/2024 |
ORGO Organogenesis | $2.29
-23.2% | 3/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Organogenesis (NASDAQ:ORGO) on 3/1/2024 |
MIRM Mirum Pharmaceuticals | $24.49
+2.0% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 2/29/2024 |
SRPT Sarepta Therapeutics | $127.39
+2.5% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/29/2024 |
SHLS Shoals Technologies Group | $8.26
-2.7% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | Analyst D. Soderberg | Overweight -> Overweight | $28.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
CYBR CyberArk Software | $245.07
+0.2% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 2/29/2024 |
MRK Merck & Co., Inc. | $130.71
+2.9% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 2/29/2024 |
FOLD Amicus Therapeutics | $10.17
-3.5% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Amicus Therapeutics (NASDAQ:FOLD) on 2/29/2024 |
DCGO DocGo | $3.49
-0.9% | 2/29/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $11.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 2/29/2024 |
ADMA ADMA Biologics | $6.44
-0.3% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 -> $8.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 2/29/2024 |
LUNR Intuitive Machines | $5.43
-0.4% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 2/29/2024 |
UHS Universal Health Services | $165.10
-0.5% | 2/29/2024 | Target Raised by | Cantor Fitzgerald | - | Underweight -> Underweight | $148.00 -> $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 2/29/2024 |
JAZZ Jazz Pharmaceuticals | $107.43
-0.8% | 2/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/29/2024 |
TDOC Teladoc Health | $13.33
-2.9% | 2/29/2024 | Initiated by | Cantor Fitzgerald | Analyst S. James | Overweight | $22.00 | Low | View details for Cantor Fitzgerald rating of Teladoc Health (NYSE:TDOC) on 2/29/2024 |
MNKD MannKind | $4.18
-0.2% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 2/28/2024 |
ACAD ACADIA Pharmaceuticals | $16.31
-1.7% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $42.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/28/2024 |
ARRY Array Technologies | $11.94
-2.4% | 2/28/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Array Technologies (NASDAQ:ARRY) on 2/28/2024 |
SSTI SoundThinking | $13.43
-0.2% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 2/28/2024 |
PGNY Progyny | $32.50
-0.3% | 2/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 2/28/2024 |
MKFG Markforged | $0.68
| 2/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $1.45 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 2/28/2024 |
DM Desktop Metal | $0.83
-1.2% | 2/28/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $1.25 | Low | View details for Cantor Fitzgerald rating of Desktop Metal (NYSE:DM) on 2/28/2024 |
SIBN SI-BONE | $14.27
-5.4% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 2/27/2024 |
ACHR Archer Aviation | $3.98
| 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 2/27/2024 |
RARE Ultragenyx Pharmaceutical | $43.85
-1.0% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/27/2024 |
BBAI BigBear.ai | $1.67
-1.2% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 2/27/2024 |
RCKT Rocket Pharmaceuticals | $22.10
-6.5% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 2/27/2024 |
SGRY Surgery Partners | $24.84
-2.6% | 2/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 2/27/2024 |
GENI Genius Sports | $5.17
-1.1% | 2/26/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Genius Sports (NYSE:GENI) on 2/26/2024 |
BMRN BioMarin Pharmaceutical | $82.17
-9.9% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/23/2024 |
HRMY Harmony Biosciences | $28.93
-1.0% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 2/23/2024 |
WULF TeraWulf | $2.49
-1.2% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 2/23/2024 |
LUNR Intuitive Machines | $5.43
-0.4% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 2/23/2024 |
RIOT Riot Platforms | $12.11
+1.9% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 2/23/2024 |
RCEL AVITA Medical | $8.30
-3.2% | 2/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 2/23/2024 |
AUPH Aurinia Pharmaceuticals | $4.87
-3.2% | 2/23/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $12.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 2/23/2024 |
ITCI Intra-Cellular Therapies | $72.13
-1.4% | 2/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $101.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 2/23/2024 |
ORIC ORIC Pharmaceuticals | $7.67
-5.1% | 2/23/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/23/2024 |
LCID Lucid Group | $2.45
-3.9% | 2/22/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Underweight | $6.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 2/22/2024 |
ROOT Root | $62.66
+4.4% | 2/22/2024 | Upgraded by | Cantor Fitzgerald | Analyst J. Siegler | Neutral -> Overweight | $9.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Root (NASDAQ:ROOT) on 2/22/2024 |
ENVX Enovix | $5.84
-3.0% | 2/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 2/21/2024 |
PANW Palo Alto Networks | $288.79
-1.7% | 2/21/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 -> $350.00 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024 |
SPT Sprout Social | $51.36
-2.1% | 2/21/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $74.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 2/21/2024 |
SABR Sabre | $2.76
| 2/21/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 2/21/2024 |
ALNY Alnylam Pharmaceuticals | $143.71
-0.1% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $165.00 | Low | View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/20/2024 |
AXSM Axsome Therapeutics | $71.52
+0.5% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $108.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/20/2024 |
BIIB Biogen | $202.46
+0.2% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | $311.00 | Low | View details for Cantor Fitzgerald rating of Biogen (NASDAQ:BIIB) on 2/20/2024 |
JNJ Johnson & Johnson | $146.82
-1.2% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 2/20/2024 |
KRTX Karuna Therapeutics | $329.83
| 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $330.00 | Low | View details for Cantor Fitzgerald rating of Karuna Therapeutics (NASDAQ:KRTX) on 2/20/2024 |
LLY Eli Lilly and Company | $724.87
-1.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 2/20/2024 |
NVO Novo Nordisk A/S | $125.80
-0.3% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $140.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 2/20/2024 |
VRTX Vertex Pharmaceuticals | $397.70
-0.8% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $440.00 | Low | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/20/2024 |
ADI Analog Devices | $197.94
+0.7% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 2/20/2024 |
AMAT Applied Materials | $197.50
+0.7% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $220.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 2/20/2024 |
AMD Advanced Micro Devices | $153.76
+1.3% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 2/20/2024 |
AVGO Broadcom | $1,294.42
+3.0% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,300.00 | Low | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 2/20/2024 |
KLAC KLA | $672.95
+2.5% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 2/20/2024 |
LRCX Lam Research | $901.47
+1.9% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 2/20/2024 |
NVDA NVIDIA | $826.32
+3.7% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $775.00 -> $900.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 2/20/2024 |
NXPI NXP Semiconductors | $238.08
+1.3% | 2/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 2/20/2024 |
